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EffEcts of fat ingEstion on gastrointEstinal 
function, appEtitE and EnErgy intakE
Gut-to-brain signaling, initiated by the sensing of nutrients in the 
small intestine, plays an important role in the regulation of GI 
function and energy intake (Schwartz, 2000). The interaction of 
nutrients, and most potently fat, with the small intestine results in 
feedback inhibition of gastric emptying (Cooke, 1977; Heddle et al., 
1989), which serves to prolong gastric distension (Read et al., 1994), 
and regulate the rate at which nutrients enter the small intestine, 
allowing for their optimal digestion and absorption. The slowing of 
gastric emptying by fat is mediated by a relaxation of the proximal 
stomach (Azpiroz and Malagelada, 1985; Feinle et al., 1996), sup-
pression of antral and duodenal pressures (Heddle et al., 1988a) 
and stimulation of tonic and phasic pyloric pressures (Heddle et al., 
1988b). The presence of fat in the small intestine also stimulates the 
secretion of a number of GI hormones, including cholecystokinin 
(CCK), glucagon-like peptide-1 (GLP-1) and peptide YY (PYY), 
and suppresses ghrelin (Feinle et al., 2003; Feinle-Bisset et al., 2005). 
The important role of these peptides in the regulation of both GI 
function and energy intake is well described (Chaudhri et al., 2008). 
However, the mechanism(s) by which the small intestine senses fat 
are currently not well understood.
It is, nonetheless, well established that it is not fat (triacylglyc-
eride) per se, but the digestive products of fat, FAs, that are sensed 
in the small intestine and are responsible for triggering the GI, and 
appetite-suppressant, effects of fat (O’Donovan et al., 2003; Feinle-
Bisset et al., 2005). Ironically, much of the evidence for this was 
obtained using pharmacological agents, such as tetrahydrolipstatin, 
the active component of the anti-obesity drugs, Xenical® (Roche) 
and Alli® (GlaxoSmithKline), which were designed to decrease die-
tary fat absorption by inhibiting lipase activity, thereby, reducing 
introduction
It is well established that the interaction of dietary fat, and spe-
cifically fatty acids (FAs), with the small intestine induces potent 
effects on gastrointestinal (GI) function (Heddle et al., 1988a; 
Herrmann et al., 1995; MacIntosh et al., 1999; Feinle-Bisset et al., 
2005) that contribute to the suppression of hunger and energy 
intake (Seimon et al., 2010). Recently, evidence has also emerged 
for a sensory system that detects the presence of FAs in the oral 
cavity (Mattes, 1996; Gilbertson, 1998; Gilbertson et al., 1998), 
and this system may also play an important role in the regulation 
of fat and energy intake (Stewart et al., 2010a). However, despite 
the potent effects of small intestinal fat on GI function and energy 
intake suppression, there is a strong positive relationship between 
the intake of dietary fat with total energy intake and body weight 
(Golay and Bobbioni, 1997), and increasing evidence that the GI 
effects of fat are attenuated following consumption of a high-fat 
diet (Boyd et al., 2003; Park et al., 2007) and in obesity (Wisen 
and Johansson, 1992; French et al., 1993; Speechly and Buffenstein, 
2000). Furthermore, a reduced ability to detect FAs in the oral 
cavity has been associated with higher energy and fat intakes, and 
higher body mass index (BMI) (Stewart et al., 2010a), suggesting 
that differences in, or impairment of, oral FA sensing mechanisms 
may contribute to overeating and obesity. This review will discuss 
current knowledge about the mechanisms underlying the effects 
of FAs on GI function and appetite, and the implications that 
changes in oral and small intestinal sensitivity to fat may have for 
the development of obesity. The review will have a particular focus 
on studies conducted in humans, however, most evidence for the 
mechanisms underlying the functional responses to fat ingestion 
comes from animal studies, and thus, animal data will be discussed 
where human data are lacking.
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increase in plasma CCK concentrations than decanoic acid (C10) 
(McLaughlin et al., 1999; Feltrin et al., 2004). Similarly, intraduo-
denal infusion of sodium oleate (C18:1), but not sodium caprylate 
(C8), stimulated CCK secretion (Matzinger et al., 2000). A similar 
pattern of effect applies to other gut hormones, e.g., C12 caused a 
significant increase in plasma GLP-1 and PYY concentrations, and 
suppressed ghrelin, whilst C10 did not (Feltrin et al., 2004, 2006). 
Once fatty chain length exceeds 12 carbon atoms, FAs appear to 
exert comparable effects on GI function. For example, the effects of 
isocaloric intraduodenal loads of C12 and C18:1 on the stimulation 
of pyloric pressures and CCK secretion are comparable (Feltrin 
et al., 2008).
Given the important role of fatty acid chain length for the effects 
of FAs on GI motility and gut hormone secretion, it is not surpris-
ing that the effects of FAs on appetite and energy intake are also 
dependent upon an acyl chain length ≥12 (Matzinger et al., 2000; 
Feltrin et al., 2004). For example, Matzinger and colleagues reported 
that C18:1 (infused at 8 mmol/h, corresponding to 0.76 kcal/min), 
but not C8, suppressed energy intake (Matzinger et al., 2000). 
Furthermore, we found that infusion of C12 (at a load of 0.4 kcal/
min) potently reduced hunger and desire to eat, and suppressed 
energy intake at a buffet meal by ∼680 kcal, when compared with 
control (Feltrin et al., 2004), confirming that the “cut-off” between 
C12 and C10, described for effects on GI motility and hormone 
release, also applies to the effects on energy intake. Within the 
group of FAs ≥C12, we evaluated the comparative effects of C12 
and C18:1, and found that C12, but not C18:1, suppressed energy 
intake (Feltrin et al., 2008), with the lack of effect of C18:1 appar-
ently in contrast to the findings of Matzinger et al. (2000). However, 
we infused at a much lower load of 0.4 kcal/min, indicating that: 
(1) the effects of C18:1 on energy intake are load-dependent, and 
the threshold load required for the suppression of energy intake 
by C18:1 is between 0.4 and 0.76 kcal/min, and (2) that, calorie 
for calorie, C12 is more potent. The mechanism(s) underlying this 
specific effect of C12 on energy intake is(are) unclear, however, 
medium chain fatty acids are more extensively oxidized in the liver 
to anorexigenic ketone bodies (Bach et al., 1996) and undergo con-
version to malonyl CoA, which is an important signal of energy 
stores in the hypothalamus and has been implicated in energy intake 
regulation (Bouchard, 2000; Lane et al., 2005). Furthermore, since 
C12 is not highly prevalent in the western diet, the GI tract of 
populations that are not regularly exposed to this FA could display 
“hypersensitivity” to its effects.
HigH-fat diEt ExposurE
While, as discussed, fat has potent effects on GI function and energy 
intake, consumption of a high-fat diet has been implicated in the 
development of obesity (Lissner and Heitmann, 1995), and high-
fat feeding is commonly used in animals studies to induce obesity 
(Woods et al., 2003). The mechanisms underlying the development 
of obesity in response to a high-fat diet are unclear, but are likely 
to be multi-factorial. There is increasing evidence that the effects 
of fat on GI function are attenuated following consumption of a 
high-fat diet (Cunningham et al., 1991; French et al., 1995; Covasa 
and Ritter, 1999, 2000; Boyd et al., 2003). Since both plasma CCK 
concentrations and pyloric pressures are independent predictors 
of acute energy intake (Seimon et al., 2010), it is conceivable that 
total energy intake. The use of lipase inhibition in clinical studies 
has, however, revealed that the digestion of fat, and consequently 
the release of FAs in the small intestinal lumen, is essential for the 
effects of fat on gastric emptying, antropyloroduodenal motility, 
GI hormone secretion, appetite and energy intake (Schwizer et al., 
1997; Borovicka et al., 2000; Matzinger et al., 2000; Feinle et al., 
2001, 2003; O’Donovan et al., 2003; Pilichiewicz et al., 2003; Degen 
et al., 2006, 2007). Thus, weight loss strategies that compromise 
nutrient digestion and absorption interfere with those GI functions 
that are involved in the suppression of energy intake, most likely 
by impairing small intestinal nutrient sensing. In support of this, 
recent evidence indicates that rather than inhibiting fat digestion, 
strategies that enhance fat digestion and/or utilize the presence of 
small amounts of FAs in the small intestine may be more effective 
in modulating appetite and energy intake and the GI functions 
underlying it (Feltrin et al., 2004; Little et al., 2005, 2007; Marciani 
et al., 2007, 2009; Seimon et al., 2009).
factors modulating tHE EffEcts of fat on 
gastrointEstinal function and EnErgy intakE
fat droplEt sizE and Emulsification
It is conceivable that enhancing both the rate of fat digestion, and 
initial gastric emptying, increases the delivery of FAs to the small 
intestine, and as a result, potentiates the effects of fat on GI func-
tion and energy intake. One way of enhancing fat digestion is to 
reduce the size of fat droplets in an emulsion. This has a profound 
effect on lipolysis since it increases the surface area available for 
the binding of lipases. For example, duodenal lipolysis of a lipid 
emulsion containing fine droplets (0.7 μm in diameter) is ∼30% 
greater than that of a lipid emulsion containing coarse droplets 
(10 μm in diameter) (Armand et al., 1999). In a recent study in 
our laboratory, we were able to demonstrate that the smaller the 
droplet size of a lipid emulsion (0.26 μm vs. 30 μm vs. 170 μm, 
infused isocalorically directly into the duodenum), the greater the 
effect on the stimulation of pyloric pressures, CCK and PYY secre-
tion, and the suppression of hunger (Seimon et al., 2009). Similarly, 
enhancing the acid stability of a fat emulsion results in an initially 
rapid phase of gastric emptying that increases the exposure of the 
small intestine to fat and its digestion products (Meyer et al., 1996, 
1999). Acid-stable emulsions have been shown to increase plasma 
CCK secretion and fullness, and suppress hunger, more potently 
than acid-unstable emulsions, in which the oil rapidly layers above 
the aqueous components and, as a result, empties into the small 
intestine much more slowly (Little et al., 2007; Marciani et al., 
2007, 2009). Taken together, these examples illustrate strategies 
that could be employed to structure fat-containing foods to enhance 
the liberation of FAs in the intestine, thereby resulting in greater 
modulation of both GI function and satiety.
acyl cHain lEngtH of fatty acids
Once FAs have been released in the process of digestion, their effects 
are critically dependent upon their acyl chain length, such that only 
FAs with a chain length of ≥12 carbon atoms notably slow gas-
tric emptying, stimulate GI hormone release and suppress energy 
intake (Hunt and Knox, 1968; Meyer et al., 1998b; McLaughlin et al., 
1999; Feltrin et al., 2004). For example, in humans, intraduodenal 
infusion of lauric acid (C12) resulted in a much more marked 
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CCK and GLP-1 concentrations in response to intraduodenal 
lipid did not differ following a high-fat, when compared with a 
low-fat, diet (Boyd et al., 2003), implicates a change in sensitivity. 
Nonetheless, both baseline plasma CCK concentrations (Little 
et al., 2008), and the plasma CCK response to a standardized 
breakfast (French et al., 1995), were increased following consump-
tion of a high-fat diet, suggesting that changes in secretion may 
also occur. The effects of exogenous CCK-8 on GI motility and 
energy intake have been reported to be maintained following 
acute exposure to a high-fat diet, when compared with an iso-
caloric low-fat diet, for a period of 3 weeks (Little et al., 2008), 
suggesting that, in lean men, and in the absence of a change in 
body weight, the sensitivity to exogenous CCK-8 is not changed 
following a short period on a high-fat diet. These results appear 
to be contrast to the reports from animal studies (Covasa et al., 
2001), however, it is unclear whether observations from studies 
in animals are applicable to humans. All of the studies conducted 
in humans were short-term and not associated with weight gain, 
hence, while differences in GI function and energy intake occur 
acutely in response to a high-fat diet, it remains unclear how 
these relate to real life, i.e., chronic consumption of a high-fat 
diet and the development of obesity. Much further work is needed 
to understand the relationships between high-fat diet exposure, 
intestinal fat sensing, energy intake and obesity. Interestingly, 
while, as discussed, there is a strong epidemiological link between 
dietary fat consumption and body weight, not all individuals who 
habitually consume a high-fat diet become overweight or obese 
(Blundell et al., 2005), and determining whether individuals who 
are resistant to weight gain maintain small intestinal sensitiv-
ity to fat, may provide important insights into the mechanisms 
underlying the development of obesity.
fatty acid sEnsing mEcHanisms in tHE 
gastrointEstinal tract
The cellular and molecular mechanisms through which FAs are 
detected in the small intestine and induce signaling to regulate 
GI function and energy intake are not well understood, although 
research on the potential receptors involved has rapidly expanded 
over the last few years. A schematic drawing summarizing cur-
rent understanding is shown in Figure 1. The recent identification 
of a number of G-protein coupled receptors (GPCRs), includ-
ing GPR120 (Hirasawa et al., 2005; Tanaka et al., 2008), GPR40 
(Edfalk et al., 2008) and GPR119 (Lan et al., 2009; Lauffer et al., 
2009), which are activated by FAs ≥ C12, or their derivatives, such 
as n-acylethanolamines (e.g., OEA), provides strong evidence for 
the existence of a GI fatty acid sensing mechanism. The recep-
tor, CD36, which plays an important role in fat absorption in the 
small intestine by transporting FAs across the cell membrane, is 
important for the production of OEA, which has been reported 
to suppress food intake (Lobo et al., 2001; Schwartz et al., 2008). 
Subsequently, post-absorptive processing of FAs with a chain 
length ≥ C12, including their packaging into chylomicrons, and 
the associated generation of apolipoprotein A-IV (apo A-IV), 
also appears to play an important role, stimulating the release of 
CCK, which in turn, activates vagal afferents to convey informa-
tion about the small intestinal environment to the brain (Glatzle 
et al., 2002, 2004).
if the stimulatory effects of fat on these GI functions are attenu-
ated by exposure to a high-fat diet, then this may also impact on 
energy intake. Indeed, in rats, exposure to a high-fat diet is associ-
ated with attenuation of the suppressive effects of small intestinal 
fat on gastric emptying (Covasa and Ritter, 2000) and food intake 
(Covasa and Ritter, 1999). Furthermore, although high-fat feeding 
has been reported to increase the CCK response to small intestinal 
oleate (Spannagel et al., 1996), the effects of intraperitoneal (i.p.) 
administration of CCK on gastric emptying (Covasa and Ritter, 
2000), hindbrain activation (Covasa et al., 2000) and energy intake 
(Covasa and Ritter, 1998; Covasa et al., 2001) in rats are attenuated 
by high-fat feeding, indicating that sensitivity to CCK is reduced 
by excess dietary fat intake. Interestingly, CCK knock-out mice 
have recently been reported to be resistant to high-fat diet-induced 
obesity (DIO), an effect that was mediated by reduced fat absorp-
tion and increased energy expenditure in these animals compared 
with wild-type controls (Lo et al., 2010), indicating that CCK may 
also play an important role in regulating body fat and body weight. 
Consumption of a high-fat diet enriched with oleic acid has also 
been reported to result in decreased small intestinal oleoyleth-
anolamine (OEA) levels in rats (Artmann et al., 2008), and it has 
been suggested that this may contribute to the increased energy 
intake associated with high-fat diets. Different strains of mice are 
resistant (diet-induced obesity-resistant, DIO-R) or prone (diet-
induced obesity-prone, DIO-P) to high-fat diet-induced obesity, 
and these models may be useful for determining the mechanisms 
underlying the development of obesity. For example, it appears 
that while in DIO-P mice exposure to a high-fat diet attenuates 
the effects of lipid on gut-to-brain signaling (measured by the 
detection of c-fos in the nucleus tractus solitarius (NTS) of the 
brainstem), these changes do not occur in DIO-R mice (Donovan 
et al., 2009).
In humans, epidemiological evidence suggests a relationship 
between the incidence of overweight and obesity with increased 
dietary fat consumption (Rolls, 1995; Golay and Bobbioni, 1997). 
In the laboratory, covert manipulation of dietary fat content 
results in an ∼15% increase in total daily energy intake on a high-
fat diet (45–50% fat), when compared with a medium-fat diet 
(30–35% fat), for 2 weeks, resulting in weight gain (Lissner et al., 
1987). A small number of short-term studies have investigated 
the effects of a high-fat diet on GI function in humans, and the 
results are often conflicting (Cunningham et al., 1991; French 
et al., 1995; Castiglione et al., 2002; Boyd et al., 2003; Little et al., 
2008), likely due to the different dietary approaches used, the 
short-term nature of the interventions (2–3 weeks), and issues 
with dietary compliance. Nonetheless, the patterns of responses 
in such studies suggest that sensitivity to the effects of fat on GI 
function and energy intake is reduced by a high-fat diet. For exam-
ple, the slowing of gastric emptying by fat (Cunningham et al., 
1991), and the stimulatory effects of intraduodenal lipid infusion 
on pyloric pressures (Boyd et al., 2003), have been reported to be 
attenuated following a high-fat diet. The underlying mechanisms 
are currently unknown. Since the stimulation of pyloric pressures 
is mediated, at least in part, by both CCK (Brennan et al., 2005) 
and GLP-1 (Schirra et al., 2000), the changes in GI motility in 
response to a high-fat diet may be due to changes in sensitivity to, 
or secretion of, these gut peptides. The observation that plasma 
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GPR40 has no effect on CCK release from STC-1 cells (Tanaka et al., 
2008). GPR119 is also expressed in L-cell models, including GLUTag 
cells, human NCI-H716 and primary rat intestinal cell lines (Lauffer 
et al., 2009). An endogenous ligand for GPR119 is OEA (Overton 
et al., 2006). GLP-1 is secreted in response to ileal perfusion of OEA 
in the rat, and knock-out of GPR119 abolishes the GLP-1 response to 
OEA in mGLUTag cells (Lauffer et al., 2009). These studies provide 
strong evidence for FA sensing mechanisms in the small intestinal 
lumen that mediate the effects of fat on GI peptide secretion. Much 
further work is needed to clarify the role of these receptors, and the 
precise underlying mechanisms, in fat sensing, how this relates to the 
regulation of energy intake in humans, and whether changes in the 
expression and/or sensitivity of these receptors underlie the devel-
opment of obesity and/or the changes in GI function and energy 
intake observed following over-exposure to dietary fat.
transduction of fatty acid-inducEd signaling: rElEasE of 
mEdiators and vagal transmission
Ingestion of fat triggers the production of OEA in the small intestine 
(Schwartz et al., 2008). In mice, peripheral administration of OEA 
has been reported to prolong the time taken to initiate the next meal 
and decrease meal frequency resulting in an overall reduction of 
food intake (Fu et al., 2008; Schwartz et al., 2008) and body weight 
(Fu et al., 2003, 2005). The production of OEA is dependent on the 
FA transporter, CD36, which mediates the uptake of FAs into the 
enterocytes. Mutant mice lacking CD36 have impaired production 
of OEA and fail to reduce their food intake in response to duodenal 
lipid (Schwartz et al., 2008). As discussed above, OEA has been shown 
to activate GPR119 (Lauffer et al., 2009), however, OEA is still able to 
reduce food intake in GPR119−/− mice, suggesting that this receptor 
does not mediate the anorexigenic effects of OEA. Instead, the effect 
of OEA to reduce food intake and body weight is mediated through 
the activation of the nuclear receptor, peroxisome-proliferator-acti-
vated receptor-α (PPAR-α) (Fu et al., 2003; Schwartz et al., 2008). The 
downstream target of PPAR-α is currently unclear, however, it may 
act by inducing apo A-IV release (Schwartz et al., 2008), a PPAR-α 
regulated protein that activates vagal afferents (Glatzle et al., 2004).
The uptake of FAs into the enterocyte is associated with the for-
mation of chylomicrons and the stimulation of apo A-IV, processes 
that have both been demonstrated to be required for the signal-
ing of information to the brain, mainly through the vagus nerve. 
For example, in rats, inhibiting chylomicron formation, using the 
“detergent” Pluronic L-81, attenuates the effects of lipid on the 
release of CCK (Raybould et al., 1998), activation of vagal afferents 
(Randich et al., 2000), and induction of c-fos like immunoreactivity 
in the NTS (Lo et al., 2007), and consequently blocks the gastric 
emptying (Raybould et al., 1998) and food intake (Meyer et al., 
1998a) responses to fat ingestion. The induction of c-fos in the 
NTS by chylomicron formation and/or signaling is dependent on 
the CCK
1
 receptor (Lo et al., 2007). Thus, the formation of chy-
lomicrons and the stimulation of apo A-IV appear to be critical for 
CCK release following ingestion of long-chain FAs. Activation of 
CCK
1
 receptors on vagal afferents, and locally on GI smooth muscle, 
then induces feedback effects on gastric emptying and food intake 
(Lo et al., 2007). In humans, the effects of FAs also appear depend-
ent on the release of CCK. For example, the inhibitory effects of 
C12 on gastric emptying and the perception of intragastric volume 
fatty acid dEtEction
Intensive research has led to the identification of a number of GPCRs 
in the small intestine, dramatically advancing our understanding 
of the molecular mechanisms underlying the sensing of dietary fat. 
These GPCRs, including GPR120 (Hirasawa et al., 2005; Tanaka 
et al., 2008), GPR40 (Edfalk et al., 2008) and GPR119 (Lan et al., 
2009; Lauffer et al., 2009), appear to be critical for the effects of fat 
on GI peptide secretion, although much of the evidence comes from 
cell line studies. The strongest evidence for a role in FA sensing exists 
for GPR120, which is activated by both saturated and unsaturated 
long-chain FAs (Miyauchi et al., 2010). GPR120 is expressed in 
the intestine of mouse and human, and in enteroendocrine cell 
lines (Hirasawa et al., 2005; Miyauchi et al., 2010), and in mice, is 
co-localized with endocrine L-cells in the large intestine (Hirasawa 
et al., 2005). In enteroendocrine cell lines, GPR120 is required for 
the fat-induced secretion of CCK (Tanaka et al., 2008) and GLP-1 
(Hirasawa et al., 2005). Furthermore, GPR120 knock-out mice have 
impaired GLP-1 secretion in response to FA ingestion (Hirasawa 
et al., 2005). Thus, GPR120 appears important in the sensing of FAs 
by enteroendocrine cells. GPR40, which is activated by medium and 
long-chain saturated and unsaturated FAs (Briscoe et al., 2003), has 
also been reported to be expressed in enteroendocrine L cells, and 
GPR40−/− mice have an impaired GLP-1 and GIP response to oral 
fat ingestion (Edfalk et al., 2008). However, the role of GPR40 in 
the secretion of other gut peptides is unclear, since knockdown of 
Figure 1 | Schematic representation of the mechanisms involved in 
small intestinal fat sensing. Fatty acids are sensed by G-protein coupled 
receptors (e.g., GPR40, GPR120, and GPR119) located on enteroendocrine 
cells. These GPCRs appear to mediate gut peptide secretion induced by small 
intestinal fatty acids. Uptake of fatty acids into the enterocyte is mediated by 
the receptor CD36. This receptor is critical for the mobilization of 
oleoylethanolamine (OEA), which has been shown to reduce food intake and 
body weight via the activation of the nuclear receptor, peroxisome-proliferator-
activated receptor-α (PPAR-α). Long chain fatty acids also stimulate 
chylomicron formation, and, in particular, the chylomicron component 
apolipoprotein A-IV (apo A-IV), is important in mediating CCK secretion and the 
effects of long-chain fatty acids on energy intake. The gut peptides released, 
such as CCK and GLP-1, interact with receptors on vagal afferent nerve 
terminals within the intestinal wall to convey signals to the brainstem and 
higher brain centers, resulting in changes in gastrointestinal function and the 
suppression of food intake.
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receptors, including CD36, delayed rectifying potassium channels, 
and a series of G-protein coupled receptors, including GPR40, GPR 
41, GPR43, and GPR120 on TRCs (Mattes, 2009b). The detection 
of FAs by these mechanisms induces a signaling cascade activating 
gustatory nerves that transmit sensory information to the NTS in the 
brainstem (Gaillard et al., 2008), and from there to higher brain cent-
ers, such as the lateral hypothalamus and the nucleus accumbens, 
which play an important role in the regulation of food intake and 
in reward. CD36 appears to play a key role in oral fat detection; 
oral exposure to long-chain FAs increases [Ca2+] in TRCs, and c-fos 
expression in the NTS, an effect that is abolished in CD36 knockout 
animals (Gaillard et al., 2008). The role of GPCRs in fat taste signal 
transduction is less clear. However, GPR120 has been reported to 
be co-localized with phospholipase Cβ2 and α-gustducin in TRCs 
(Matsumura et al., 2009), both of which are involved in the trans-
duction of other tastes, such as sweetness and bitterness.
pHysiological rEsponsEs inducEd by oral fatty acids
Oral sensing of FAs appears to have two major roles: (i) mediation 
of cephalic phase responses and (ii) contribution to the regulation 
of fat and energy intake. Oral stimulation with fat, using modified 
sham-feeding techniques, has been reported in humans to stimulate 
gastric lipase secretion (Wojdemann et al., 1997), elevate serum 
triglycerides (Mattes, 2009a), suppress ghrelin (Heath et al., 2004), 
and to reduce appetite (Heath et al., 2004; Smeets and Westerterp-
Plantenga, 2006; Smeets et al., 2009) and energy intake (Crystal 
and Teff, 2006).
sEnsitivity to oral fatty acids and diEtary fat  
prEfErEncE and intakE
Heightened preference for, and increased consumption of, fatty 
foods amongst the obese suggests that fat intake is poorly regulated 
in this group (Mela and Sacchetti, 1991), raising the question of 
relationships between oral fat sensitivity, fat intake and obesity. In 
animals, FA sensitivity appears to vary across strains; e.g., DIO-P 
(Osborne–Mendel) rats have decreased oral FA acid sensitivity when 
compared with DIO-R (S5B/PL) rats (Gilbertson et al., 2005). The 
greater oral sensitivity in the DIO-R rats is associated with reduced 
fat intake, reduced preference for fat, and reduced predisposition for 
obesity when compared with DIO-P rats (Gilbertson et al., 1998). 
These observations provide compelling evidence that oral FA sen-
sitivity contributes to dietary fat preference, energy intake and, 
consequently, body weight. Similarly, human studies have identified 
a large diversity in oral sensitivity to FAs, with detection thresholds 
ranging from 0.02–12 mM, although all subjects appeared able to 
detect FAs across this range (Stewart et al., 2010a,b). Those indi-
viduals who were defined as “hypersensitive” to C18:1 (those able 
to detect C18:1 at a concentration of 1.4 mM) had significantly 
lower habitual dietary energy and fat intakes and body weights than 
those defined as hyposensitive (those unable to detect the presence 
of 1.4 mM oleic acid) (Stewart et al., 2010a). In a further study 
(Stewart et al., 2010b), obese subjects, as a group, had significantly 
higher detection thresholds for C18:1, and intraduodenal infusion 
of C18:1 was associated with reduced stimulation of pyloric motil-
ity, when compared with lean individuals, indicating that the obese 
are less able to sense, and induce appropriate signaling responses 
to, both oral and intestinal fat (Figure 2).
(maximum volume tolerated) (Lal et al., 2004), and the inhibitory 
effects of C18:1 on energy intake (Matzinger et al., 2000), were 
attenuated by the CCK
1
 receptor antagonist, dexloxiglumide. A 
recent study in humans, using functional magnetic resonance imag-
ing, has demonstrated that C12 increases activity in the brainstem 
and hypothalamus, and that this effect is dependent on the CCK
1
 
receptor (Lassman et al., 2010), thus, in man, the sensing of lipid 
by the small intestine appears to also be signaled to the brainstem 
and hypothalamus via a CCK
1
 receptor mediated pathway. As the 
response was rapid (occurring within 2–4 min following C12 infu-
sion), it is consistent with a vagally mediated response.
Taken together, it appears that small intestinal FAs are detected 
by GPCRs located on enteroendocrine cells to stimulate GI peptide 
release, and also by the mobilization of OEA, and chylomicron 
components, in particular apo A-IV, which in turn induce gut pep-
tide secretion. These gut peptides interact with receptors on vagal 
afferent nerve terminals within the intestinal wall, conveying infor-
mation about the small intestinal environment to the brainstem 
and higher brain centers, resulting in changes in GI function and 
behavioral responses, including the suppression of food intake.
oral fat “tastE”: rolE of oral fatty acid dEtEction in 
diEtary prEfErEncE and tHE rEgulation of gi 
function and EnErgy intakE
The taste of food is an important determinant of the amount con-
sumed at a meal. Fat, in particular, increases the palatability of foods 
and can, therefore, lead to over-consumption. It has long been estab-
lished that the presence of food in the oral cavity also induces physi-
ological responses, including gastric and pancreatic secretion, as part 
of the so-called “cephalic phase”, which prepares the GI tract for nutri-
ent exposure, thereby optimizing nutrient digestion and absorption. 
While it is well established that the human gustatory system can detect 
the taste qualities of sweet, sour, bitter, salty, and umami, more recently 
the existence of a sixth detection (“taste”) modality responsive to 
FAs has been revealed (Abumrad, 2005; Chale-Rush et al., 2007a,b; 
Gaillard et al., 2008; Mattes, 2009b). Dietary fats, i.e., triacylglycerols, 
do not appear to be effective stimuli per se; in analogy to intestinal fat 
sensing, the detection of fat in the oral cavity appears to be dependent 
on the presence of FAs. In humans, sensory detection of FAs occurs 
within the millimolar range (0.02–6.4 mM) (Stewart et al., 2010a). It 
has been argued that in humans the oral cavity would not be exposed 
to FAs as the presence of lingual lipase has been debated, however, 
this detection threshold is consistent with the concentrations of FAs 
naturally present in foods (0.76–3% w/v), and lipolytic activity in 
saliva has recently been shown to be sufficient to produce micromo-
lar amounts of fatty acids within the detectable range (Stewart et al., 
2010a). Importantly, the receptors implicated in oral FA detection 
have been characterized as analogous to those involved in small intesti-
nal FA sensing. The following will discuss the mechanisms underlying 
oral FA detection, the physiological responses induced by the detection 
of FA in the oral cavity, and recent evidence that sensitivity to oral 
FAs is related to dietary fat preference and intake.
oral fatty acid dEtEction
Oral detection of nutrients occurs as a result of the interaction of 
nutrients with receptors on the apical surface of taste receptor cells 
(TRCs). Animal studies have revealed the expression of a number of 
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fat/energy to receive the same reward/satisfaction. Furthermore, 
since an individual’s perception of reward is also likely to be related 
to psychological factors, such as if they have experienced aversive 
responses to particular foods, or if certain foods were provided as 
a reward for good behavior when they were children, it will also be 
important to determine whether such psychological factors have 
the ability to influence oral sensitivity to FAs (Rolls, 2010).
conclusions and implications
This review has summarized our current understanding of the 
mechanisms involved in the sensing of fat both in the oral cavity 
and small intestinal lumen, and the potent effects elicited by fat on 
GI function, including changes in motor function and secretion of 
gut peptides, which lead to the suppression of appetite and energy 
intake. The knowledge of the cellular and molecular mechanisms 
underlying both oral and intestinal fat sensing has increased dra-
matically in recent years, however, much further work is needed to 
fully characterize these mechanisms, particularly in humans where 
data are currently scarce. It will be critical to determine the role of 
these mechanisms in the regulation of normal energy intake and 
reward, whether modulation of expression and/or sensitivity of 
these receptors predisposes to obesity, or mediates the development 
of obesity following dietary overconsumption (particularly of fat), 
and whether, for example, impaired oral and intestinal sensing of 
dietary fat, as observed in obesity, can be restored by energy restric-
tion. Ultimately, these mechanisms may then provide exciting new 
targets for the treatment, or prevention, of obesity.
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Given the homology between the receptors involved in oral and 
intestinal fat sensing, this observation raises the possibility that 
receptor expression/sensitivity may be altered in obesity in both 
the oral cavity and the GI tract. Whether those individuals prone 
to obesity have altered expression of fat sensing receptors (i.e., 
decreased expression of receptors such as CD36 and GPR120 in 
the oral cavity and small intestine), or whether receptor expression/
sensitivity is altered by factors that contribute to the development 
of obesity (i.e., induced by changes in environmental factors such 
as prolonged exposure to a high-fat diet), is currently unknown. 
However, given evidence of impaired small intestinal fat sensing 
following high-fat diet exposure, it is conceivable that dietary over-
exposure to fat also modulates oral fat sensing. In order to under-
stand the mechanisms underlying differences in oral fat detection, 
research is warranted to determine whether receptor expression/
sensitivity can be modulated by energy/fat restriction to restore 
oral and intestinal signaling responses to fat.
rEward-rElatEd Eating
Food is ingested not only to replenish energy stores, but also because 
it is enjoyable and rewarding, and this may particularly relate to 
fat-containing foods, due to their high palatability. Thus, dietary 
fat does not only influence homeostatic pathways, as discussed 
above, but there is increasing evidence that it can powerfully modify 
food intake by activating hedonic pathways, increasing the desire to 
consume foods that are highly palatable (Lutter and Nestler, 2009). 
For example, studies using fMRI have demonstrated in humans 
that oral exposure to dietary fat activates reward areas, such as 
the lateral hypothalamus, amygdala, insula, and anterior cingulate 
cortex (De Araujo and Rolls, 2004), and this may be enhanced in 
obesity (Rolls, 2010). It is currently not known how differences in 
the ability to detect fat in the oral cavity contribute to differences in 
food preference and reward-related eating and, thus, overall energy 
intake. Studies are warranted to evaluate whether these hedonic 
effects of fat are related to oral fat taste sensitivity, i.e., whether indi-
viduals with reduced sensitivity to oral fat need to consume more 
Figure 2 | relationship between (A) oral detection threshold for oleic acid (C18:1) and (B) the total number of isolated pyloric pressure waves (IPPWs) following 
intraduodenal infusion of C18:1 (0.76 kcal/min for 90 min), with body mass index (BMI, kg/m2) in both lean (n = 10) and obese (n = 9) subjects (Stewart et al., 2010b).
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